RAMSAY GENERALE DE SANTE SA (GDS.PA) Stock Fundamental Analysis
Europe - EPA:GDS - FR0000044471 - Common Stock
10.25 EUR
+0.05 (+0.49%)
Overall GDS gets a fundamental rating of 2 out of 10. We evaluated GDS against 32 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of GDS have multiple concerns. GDS is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year GDS has reported negative net income.
GDS had a positive operating cash flow in the past year.
In multiple years GDS reported negative net income over the last 5 years.
Each year in the past 5 years GDS had a positive operating cash flow.
1.2 Ratios
GDS's Return On Assets of -0.79% is on the low side compared to the rest of the industry. GDS is outperformed by 87.50% of its industry peers.
GDS has a worse Return On Equity (-4.72%) than 84.38% of its industry peers.
GDS's Return On Invested Capital of 2.64% is on the low side compared to the rest of the industry. GDS is outperformed by 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GDS is below the industry average of 6.78%.
The last Return On Invested Capital (2.64%) for GDS is above the 3 year average (1.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROIC | 2.64% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
1.3 Margins
GDS has a Operating Margin (3.57%) which is comparable to the rest of the industry.
GDS's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 77.91%, GDS is doing good in the industry, outperforming 78.13% of the companies in the same industry.
GDS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% |
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
GDS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GDS remains at a similar level compared to 1 year ago.
The number of shares outstanding for GDS remains at a similar level compared to 5 years ago.
GDS has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.01, we must say that GDS is in the distress zone and has some risk of bankruptcy.
GDS's Altman-Z score of 1.01 is on the low side compared to the rest of the industry. GDS is outperformed by 62.50% of its industry peers.
GDS has a debt to FCF ratio of 7.41. This is a slightly negative value and a sign of low solvency as GDS would need 7.41 years to pay back of all of its debts.
GDS has a Debt to FCF ratio (7.41) which is comparable to the rest of the industry.
A Debt/Equity ratio of 3.27 is on the high side and indicates that GDS has dependencies on debt financing.
GDS has a Debt to Equity ratio of 3.27. This is in the lower half of the industry: GDS underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Altman-Z | 1.01 |
ROIC/WACC0.58
WACC4.53%
2.3 Liquidity
GDS has a Current Ratio of 0.81. This is a bad value and indicates that GDS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.81, GDS is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that GDS may have some problems paying its short term obligations.
GDS has a Quick ratio (0.73) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The earnings per share for GDS have decreased by -0.33% in the last year.
The Revenue has been growing slightly by 4.70% in the past year.
The Revenue has been growing slightly by 6.95% on average over the past years.
EPS 1Y (TTM)-0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.77%
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%98.83%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GDS. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDS indicates a somewhat cheap valuation: GDS is cheaper than 71.88% of the companies listed in the same industry.
96.88% of the companies in the same industry are more expensive than GDS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.05 | ||
| EV/EBITDA | 7.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
GDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GDS (10/3/2025, 7:00:00 PM)
10.25
+0.05 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap1.13B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 2.05 | ||
| P/OCF | 1.63 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.75 |
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.99
FCFY48.69%
OCF(TTM)6.28
OCFY61.31%
SpS47.49
BVpS10.37
TBVpS-10.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROCE | 3.59% | ||
| ROIC | 2.64% | ||
| ROICexc | 2.85% | ||
| ROICexgc | 5.42% | ||
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% | ||
| FCFM | 10.51% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
ROICexc(3y)2.04%
ROICexc(5y)1.59%
ROICexgc(3y)3.83%
ROICexgc(5y)2.97%
ROCE(3y)2.58%
ROCE(5y)2.01%
ROICexcg growth 3Y44.11%
ROICexcg growth 5Y31.78%
ROICexc growth 3Y41.72%
ROICexc growth 5Y29.83%
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
F-Score3
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Debt/EBITDA | 6.03 | ||
| Cap/Depr | 32.9% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 0.99 | ||
| Cash Conversion | 111.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 1.01 |
F-Score3
WACC4.53%
ROIC/WACC0.58
Cap/Depr(3y)38.37%
Cap/Depr(5y)42.77%
Cap/Sales(3y)3.25%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%98.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.13%
EBIT growth 3Y38.66%
EBIT growth 5Y31.31%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.7%
FCF growth 3Y99.96%
FCF growth 5Y-0.36%
OCF growth 1Y18.22%
OCF growth 3Y38.26%
OCF growth 5Y-1%